Remgro, chaired by Johann Rupert, reported a net asset value of R292.34 per share as of June 2025 and has been engaged in a divestment strategy over the past six years.
The latest of this strategy is selling nearly 52 million FirstRand shares for R4.88 billion ($296 million) as the company stands at a R509 billion market cap.
The rationale for this sale, which was sold at an average price of R93.87 per share, according to the company, is to bolster its strategic cash reserves and its capital allocation framework.
“The proceeds from the disposal add to Remgro’s strategic cash resources, which are managed in accordance with its capital allocation framework,” the company said.
Remgro
Remgro, one of the Rupert family’s oldest businesses, was established in the 2000s when the Rupert-founded investment conglomerate Rembrandt split into two publicly traded firms.
VenFin, which oversaw the company’s technological investments, and Remgro, which oversaw its conventional assets, were two of these firms.
These businesses reunited to form Remgro in 2009, and the investment behemoth has since expanded.
In 2020, the company decided to begin selling its holdings, beginning with its 28.2 percent stake in RMB Holdings.
In 2020, JSE-listed assets made up 77% of Remgro’s portfolio, as seen in Daily Investor.
The business made the decision to build a portfolio of significantly distinctive and appealing exposures.
Following the failure of RMI Holdings, the company that previously held Remgro’s insurance assets, OUTsurance was listed in 2022.
Additionally, in June 2023, the business, in partnership with Mediterranean Shipping Company SA, also delisted Mediclinic International.
As a result, the company has inched further towards its goals of boasting a more unique portfolio.
“We have successfully executed on our strategy to optimise and reposition our portfolio and, through embedding these transformative actions, laid the foundation for unlocking sustainable shareholder value,” Durand said in Remgro’s 2025 Annual Report.
